From: Results of the 2018 Japan Society for Blood Purification in Critical Care survey: current status and outcomes
Hemofilters
PS
PMMA
AN69ST
Others
P value
n (%)
675 (36.2)
440 (23.6)
412 (22.1)
337 (18.1)
–
28-day survival rate (%)
58.5
52.7
54.1
70.8
 < 0.0001